Aevi Genomic Medicine Competitors and Similar CompaniesClear all

Aevi Genomic Medicine's competitors and similar companies include Nouscom, MicrofluidX and CAMP4 Therapeutics.
Aevi Genomic Medicine
Aevi Genomic Medicine
Aevi Genomic Medicine is dedicated to translating genetic discoveries into novel therapies.
Nouscom
Nouscom
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
MicrofluidX
MicrofluidX
MicrofluidX is a company that develops cell bioprocessing technology.
CAMP4 Therapeutics
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
Founding Date
Founding Date
2000
Founding Date
2015
Founding Date
2018
Founding Date
2016
Type
Type
Subsidiary
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Wayne, US HQ
Locations
Basel, CH HQ
Roma, IT
Locations
HQ
Locations
Cambridge, US HQ
Employees
Employees
24
Employees
633% increase
Employees
405% decrease
Employees
66

Financial

Net income
Net income
($41.9m) (FY, 2016)
Net income
N/A
Net income
N/A
Net income
($80.4m) (FY, 2025)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 49m (over 8 years ago)
Latest funding round
$ 1.7m (about 6 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 62.6m
Total funding raised
$ 1.7m
Total funding raised
$ 30m
For sources of this data, please see the company profile

View Company Profiles

Nouscom
HQ
Basel, CH
Employees
63↑ 3% increase

Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

View company
MicrofluidX
HQ
Employees
40↓ 5% decrease

MicrofluidX is a company that develops cell bioprocessing technology.

View company
CAMP4 Therapeutics
HQ
Cambridge, US
Employees
66

CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.

View company